ArticleJournal of gastrointestinal cancer2026

Sintilimab Plus Nanoparticle Polymeric Micellar Paclitaxel and S-1 as First-Line Treatment in HER2-Negative Advanced Gastric Cancer: A Real-World Study.

Yu-Qing Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.